Related Articles by Review for PMID: 31082098

Year	Number of Results
2019	3
2020	4
2021	3
2022	1
2023	2
2025	1

1

Azhar Y, Din AU. Azhar Y, et al. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31082098 Free Books & Documents.

2

Brexanolone, a GABA_A Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review.

Edinoff AN, Odisho AS, Lewis K, Kaskas A, Hunt G, Cornett EM, Kaye AD, Kaye A, Morgan J, Barrilleaux PS, Lewis D, Viswanath O, Urits I. Edinoff AN, et al. Front Psychiatry. 2021 Sep 14;12:699740. doi: 10.3389/fpsyt.2021.699740. eCollection 2021. Front Psychiatry. 2021. PMID: 34594247 Free PMC article. Review.

3

Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.

Leader LD, O'Connell M, VandenBerg A. Leader LD, et al. Pharmacotherapy. 2019 Nov;39(11):1105-1112. doi: 10.1002/phar.2331. Epub 2019 Oct 7. Pharmacotherapy. 2019. PMID: 31514247 Review.

4

Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?

Faden J, Citrome L. Faden J, et al. Ther Adv Psychopharmacol. 2020 Nov 9;10:2045125320968658. doi: 10.1177/2045125320968658. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 33224470 Free PMC article. Review.

5

Brexanolone to Treat Postpartum Depression in Adult Women.

Cornett EM, Rando L, Labbé AM, Perkins W, Kaye AM, Kaye AD, Viswanath O, Urits I. Cornett EM, et al. Psychopharmacol Bull. 2021 Mar 16;51(2):115-130. Psychopharmacol Bull. 2021. PMID: 34092826 Free PMC article. Review.

6

Brexanolone: A Novel Drug for the Treatment of Postpartum Depression.

Patatanian E, Nguyen DR. Patatanian E, et al. J Pharm Pract. 2022 Jun;35(3):431-436. doi: 10.1177/0897190020979627. Epub 2020 Dec 11. J Pharm Pract. 2022. PMID: 33302791 Review.

7

Brexanolone for postpartum depression: A meta-analysis of randomized controlled studies.

Zheng W, Cai DB, Zheng W, Sim K, Ungvari GS, Peng XJ, Ning YP, Wang G, Xiang YT. Zheng W, et al. Psychiatry Res. 2019 Sep;279:83-89. doi: 10.1016/j.psychres.2019.07.006. Epub 2019 Jul 4. Psychiatry Res. 2019. PMID: 31323375 Review.

8

Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression.

Powell JG, Garland S, Preston K, Piszczatoski C. Powell JG, et al. Ann Pharmacother. 2020 Feb;54(2):157-163. doi: 10.1177/1060028019873320. Epub 2019 Sep 3. Ann Pharmacother. 2020. PMID: 31476884 Review.

9

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.

Reddy DS, Mbilinyi RH, Estes E. Reddy DS, et al. Psychopharmacology (Berl). 2023 Sep;240(9):1841-1863. doi: 10.1007/s00213-023-06427-2. Epub 2023 Aug 11. Psychopharmacology (Berl). 2023. PMID: 37566239 Free PMC article. Review.

10

Brexanolone for postpartum depression.

Hutcherson TC, Cieri-Hutcherson NE, Gosciak MF. Hutcherson TC, et al. Am J Health Syst Pharm. 2020 Feb 19;77(5):336-345. doi: 10.1093/ajhp/zxz333. Am J Health Syst Pharm. 2020. PMID: 32073124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31082098

11 results

Results by year